227 related articles for article (PubMed ID: 34233378)
21. A randomized split-face comparative study of long-pulsed alexandrite plus low-fluence Nd:YAG laser versus pulsed-dye laser in the treatment of rosacea.
Park S; Lee JH; Kang E; Kim H; Kim JY; Lee EJ; Bae YJ; Kim J; Oh SH
Lasers Surg Med; 2022 Nov; 54(9):1217-1225. PubMed ID: 36183378
[TBL] [Abstract][Full Text] [Related]
22. Role of Topical Oxymetazoline for Management of Erythematotelangiectatic Rosacea.
Hoover RM; Erramouspe J
Ann Pharmacother; 2018 Mar; 52(3):263-267. PubMed ID: 29094614
[TBL] [Abstract][Full Text] [Related]
23. Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser.
Ying H; Zou Y; Yu W; Qiu Y; Ma G; Chang L; Gu Y; Lyu D; Lin X
J Dermatol; 2017 Jun; 44(6):660-665. PubMed ID: 28191657
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety comparison between pulsed dye laser and intense pulsed light configured with different wavelength bands in treating erythematotelangiectatic rosacea.
Ruan J; Zheng Y; Cai S
Lasers Med Sci; 2024 Jun; 39(1):146. PubMed ID: 38822948
[TBL] [Abstract][Full Text] [Related]
25. Comparison of efficacy between long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia.
Kwon WJ; Park BW; Cho EB; Park EJ; Kim KH; Kim KJ
J Cosmet Laser Ther; 2018 Oct; 20(5):260-264. PubMed ID: 29388843
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
[TBL] [Abstract][Full Text] [Related]
27. Pulsed dye laser treatment of rosacea using a novel 15 mm diameter treatment beam.
Bernstein EF; Schomacker K; Paranjape A; Jones CJ
Lasers Surg Med; 2018 Oct; 50(8):808-812. PubMed ID: 29635699
[TBL] [Abstract][Full Text] [Related]
28. EMLA cream does not influence efficacy and pain reduction during pulsed-dye laser treatment of port-wine stain: a prospective side-by-side comparison.
Yu W; Wang T; Zhu J; Qiu Y; Chen H; Jin Y; Yang X; Hu X; Chang L; Chen Y; Ma G; Lin X
Lasers Med Sci; 2018 Apr; 33(3):573-579. PubMed ID: 29247433
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 532 nm Potassium Titanyl Phosphate Laser and 595 nm Pulsed Dye Laser in the Treatment of Erythematous Surgical Scars: A Randomized, Controlled, Open-Label Study.
Keaney TC; Tanzi E; Alster T
Dermatol Surg; 2016 Jan; 42(1):70-6. PubMed ID: 26673432
[TBL] [Abstract][Full Text] [Related]
30. Neodymium-yttrium aluminum garnet laser versus pulsed dye laser in erythemato-telangiectatic rosacea: comparison of clinical efficacy and effect on cutaneous substance (P) expression.
Salem SA; Abdel Fattah NS; Tantawy SM; El-Badawy NM; Abd El-Aziz YA
J Cosmet Dermatol; 2013 Sep; 12(3):187-94. PubMed ID: 23992160
[TBL] [Abstract][Full Text] [Related]
31. Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial.
Greveling K; Prens EP; van Doorn MB
Lasers Surg Med; 2017 Jan; 49(1):104-109. PubMed ID: 27320685
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
Huang YC; Chou CL; Chiang YY
Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
[TBL] [Abstract][Full Text] [Related]
33. The Efficacy of Pulsed Dye Laser Pretreated With or Without Local Anesthetic on Patients Presenting With Erythema of Face, Neck, Chest, and Extremities.
Chunharas C; Boen M; Alhaddad M; Wu DC
Lasers Surg Med; 2020 Apr; 52(4):307-314. PubMed ID: 31441076
[TBL] [Abstract][Full Text] [Related]
34. Enhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: a randomized, prospective, split-face trial.
Kim TG; Roh HJ; Cho SB; Lee JH; Lee SJ; Oh SH
Br J Dermatol; 2011 Mar; 164(3):573-9. PubMed ID: 21143465
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of long-term efficacy, safety, and effect on life quality of pulsed dye laser in rosacea patients.
Bulbul Baskan E; Akin Belli A
J Cosmet Laser Ther; 2019; 21(4):185-189. PubMed ID: 30040521
[No Abstract] [Full Text] [Related]
36. Difference in vasoconstrictors: oxymetazoline vs. brimonidine.
Okwundu N; Cline A; Feldman SR
J Dermatolog Treat; 2021 Mar; 32(2):137-143. PubMed ID: 31294643
[TBL] [Abstract][Full Text] [Related]
37. Prospective Comparison of Dual Wavelength Long-Pulsed 755-nm Alexandrite/1,064-nm Neodymium:Yttrium-Aluminum-Garnet Laser versus 585-nm Pulsed Dye Laser Treatment for Rosacea.
Seo HM; Kim JI; Kim HS; Choi YJ; Kim WS
Ann Dermatol; 2016 Oct; 28(5):607-614. PubMed ID: 27746641
[TBL] [Abstract][Full Text] [Related]
38. Multiple sequential light and laser sources to activate aminolevulinic acid for rosacea.
Friedmann DP; Goldman MP; Fabi SG; Guiha I
J Cosmet Dermatol; 2016 Dec; 15(4):407-412. PubMed ID: 27378246
[TBL] [Abstract][Full Text] [Related]
39. Rosacea: new and emerging treatments.
Moustafa FA; Sandoval LF; Feldman SR
Drugs; 2014 Sep; 74(13):1457-65. PubMed ID: 25154627
[TBL] [Abstract][Full Text] [Related]
40. Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks.
Chang CJ; Hsiao YC; Mihm MC; Nelson JS
Lasers Surg Med; 2008 Nov; 40(9):605-10. PubMed ID: 18951427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
